US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Soligenix, Inc.

2.06

+0.06003.00%

Post-market: 2.00-0.0600-2.91%19:57 EDT

Volume:112.04K

Turnover:229.17K

Market Cap:6.50M

PE:-0.41

High:2.11

Open:2.08

Low:1.96

Close:2.00

Loading ...

Overview Company News Filings

EXCLUSIVE: Soligenix Starts Confirmatory Late-Stage Trial For HyBryte For Type Of Blood Cancer

Winter 2024 Investor Summit Virtual: Q4 Presentations Now Available for On-Demand Viewing

BRIEF-HyBryte Clinical Results Demonstrate Continued Improvement Post-Treatment

Hybryte™ Clinical Results Demonstrate Continued Improvement Post-Treatment

THOMSON REUTERS

Soligenix Inc: Hybryte Was Well Tolerated in All Patients

THOMSON REUTERS

Soligenix: 1 of 5 Patients Receiving Valchlor Had to Be Withdrawn From Trial Due to a Clinically Significant Allergic Contact Dermatitis

THOMSON REUTERS

DealFlow Events Unveils First Wave of Companies for The Microcap Conference in January 2025

BRIEF-Soligenix Announces Formation Of European Medical Advisory Board For Cutaneous T-Cell Lymphoma

Soligenix forms European Medical Advisory Board

Soligenix Announces Formation of European Medical Advisory Board for Cutaneous T-Cell Lymphoma

THOMSON REUTERS

Soligenix Third Quarter 2024 Earnings: US$0.78 loss per share (vs US$2.56 loss in 3Q 2023)

Simply Wall St.

Soligenix initiates Phase 2 clinical trial of SGX945 in Behcet’s Disease

Soligenix Kickstarts Dusquetide Mid-Stage Study For Patients With Inflamed Blood Vessels

Soligenix Initiates a Phase 2 Clinical Trial of Sgx945 (Dusquetide) for the Treatment of BehÇEt's Disease

THOMSON REUTERS

SNGX: Phase 3 CTCL Trial to Initiate Before End of 2024

Zacks Small Cap Research

Soligenix Third Quarter 2024 Earnings: US$0.78 loss per share (vs US$2.56 loss in 3Q 2023)

Simply Wall St.

Soligenix Inc expected to post a loss of $1.09 a share - Earnings Preview

Soligenix Qtrly Share Loss $0.78

THOMSON REUTERS

Soligenix Announces Recent Accomplishments and Third Quarter 2024 Financial Results

THOMSON REUTERS

Press Release: Soligenix Announces Recent Accomplishments And Third Quarter 2024 Financial Results

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/SNGX/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"SNGX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SNGX\",,,,,undefined,":{"symbol":"SNGX","market":"US","secType":"STK","nameCN":"Soligenix, Inc.","latestPrice":2.06,"timestamp":1744833600000,"preClose":2,"halted":0,"volume":112038,"hourTrading":{"tag":"盘后","latestPrice":2,"preClose":2.06,"latestTime":"19:57 EDT","volume":7251,"amount":14848.71,"timestamp":1744847841253},"delay":0,"floatShares":3154934,"shares":3155603,"eps":-4.978626,"marketStatus":"Closed","change":0.06,"latestTime":"04-16 16:00:00 EDT","open":2.08,"high":2.11,"low":1.9583,"amount":229166.6257908,"amplitude":0.07585,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-4.978626,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1744876800000},"marketStatusCode":5,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":2,"preHourTrading":{"tag":"盘前","latestPrice":2.09,"preClose":2,"latestTime":"09:26 EDT","volume":1232,"amount":2440.5535616,"timestamp":1744809961908},"postHourTrading":{"tag":"盘后","latestPrice":2,"preClose":2.06,"latestTime":"19:57 EDT","volume":7251,"amount":14848.71,"timestamp":1744847841253},"volumeRatio":0.162138},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SNGX\",,,,,undefined,":{"symbol":"SNGX","floatShares":3154934,"roa":"-62.88%","roe":"-248.97%","lyrEps":-4.978626,"volumeRatio":0.162138,"shares":3155603,"dividePrice":0,"high":2.11,"amplitude":0.07585,"preClose":2,"low":1.9583,"week52Low":1.68,"pbRate":"1.58","psRate":"54.46","week52High":14.8299,"institutionHeld":0.0042,"latestPrice":2.06,"eps":-4.978626,"divideRate":0,"volume":112038,"delay":0,"ttmEps":-4.978626,"open":2.08,"prevYearClose":2.695,"prevWeekClose":2.175,"prevMonthClose":2.15,"prevQuarterClose":2.15,"fiveDayClose":1.95,"twentyDayClose":2.33,"sixtyDayClose":2.4},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"SNGX\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2491698224","title":"EXCLUSIVE: Soligenix Starts Confirmatory Late-Stage Trial For HyBryte For Type Of Blood Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2491698224","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491698224?lang=en_us&edition=fundamental","pubTime":"2024-12-16 20:15","pubTimestamp":1734351316,"startTime":"0","endTime":"0","summary":"On Monday, Soligenix, Inc.  said it has opened patient enrollment for its confirmatory Phase 3 study evaluating HyBryte  for cutaneous T-cell lymphoma .The confirmatory Phase 3 study, FLASH2, builds on the previous statistically significant Phase 3  study, as well as a recent comparative study  and an ongoing investigator-initiated study, each further supporting the design of the FLASH2 clinical trial.Also Read: Soligenix Kickstarts Dusquetide Mid-Stage Study For Patients With Inflamed Blood Vessels. The FLASH2 study is expected to enroll patients in the U.S. and Europe, and a formal interim analysis is anticipated early in 2026.The company looks forward to providing periodic updates on the trial's progress in 2025. FLASH2 will enroll approximately 80 subjects with early-stage CTCL, a group of rare blood cancers that affect the skin.The extended treatment for a continuous 18 weeks in a single cycle is expected to statistically demonstrate the effect of HyBryte over a more prolonged, \"r","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/1N9wJ_JuKqJJT7b.NQp62A--~B/aD01NTM7dz05ODM7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/Benzinga/b6f51e37681f48ad3ecc673c5195f0db","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/1N9wJ_JuKqJJT7b.NQp62A--~B/aD01NTM7dz05ODM7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/Benzinga/b6f51e37681f48ad3ecc673c5195f0db"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/exclusive-soligenix-starts-confirmatory-stage-121516113.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["SSI","BK4139","SNGX"],"gpt_icon":0},{"id":"2488976817","title":"Winter 2024 Investor Summit Virtual: Q4 Presentations Now Available for On-Demand Viewing","url":"https://stock-news.laohu8.com/highlight/detail?id=2488976817","media":"ACCESSWIRE","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488976817?lang=en_us&edition=fundamental","pubTime":"2024-12-04 04:45","pubTimestamp":1733258700,"startTime":"0","endTime":"0","summary":"NEW YORK, NY / ACCESSWIRE / December 3, 2024 / Investor Summit Group, committed to advancing the MicroCap and SmallCap investment community, announces that the November 21, 2024 Winter Investor Summit Virtual Conference presentations are now available for on-demand viewing.Participants and those unable to attend can now access the presentations at their convenience:. Click the Presentation Links Below To Access Presentations:. Forum Energy Tech Presentation Investor Summit November 21. To learn more and gain insights from the event, visit the Investor Summit Group website and explore valuable content shared by industry experts.We believe in connecting investors with the best microcap and smallcap companies. We are an independent company dedicated to fostering a unique and valuable ecosystem where investors can discover promising opportunities. Our carefully curated events feature companies with strong fundamentals and growth potential,","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/MyZHbHdNhq61VfcrOcPIIA--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/accesswire.ca/7cd0e09f71d981c181d1161115c223c6","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/MyZHbHdNhq61VfcrOcPIIA--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/accesswire.ca/7cd0e09f71d981c181d1161115c223c6"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/winter-2024-investor-summit-virtual-204500775.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4164","SMMF","ACFN","BK4082","BK4211","OESX","LMFA","IMRN","BK4139","AUUD","BLGO","ULY","NQmain","SNGX","TQQQ","IMUX","ACON","BK4148","QLD","BK4182","BK4109","PSQ","BK4179","QID","BK4023","ACONW","BK4190","BK4167","NMTC","PLUR","HLRTF","CPSH","SQQQ","FET","BK4213","BK4096","AUUDW","MNQmain","TGCB","SPGC","BK4157",".IXIC","SOTK"],"gpt_icon":1},{"id":"2488267566","title":"BRIEF-HyBryte Clinical Results Demonstrate Continued Improvement Post-Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2488267566","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488267566?lang=en_us&edition=fundamental","pubTime":"2024-12-02 20:41","pubTimestamp":1733143304,"startTime":"0","endTime":"0","summary":"Dec 2  - Soligenix Inc   :   * HYBRYTE CLINICAL RESULTS DEMONSTRATE CONTINUED IMPROVEMENT POST-TREATMENT   * SOLIGENIX: 1 OF 5 PATIENTS RECEIVING VALCHLOR HAD TO BE WITHDRAWN FROM TRIAL DUE TO A CLINICALLY SIGNIFICANT ALLERGIC CONTACT DERMATITIS   * SOLIGENIX INC: HYBRYTE WAS WELL TOLERATED IN ALL PATIENTSSource text:    Further company coverage:    ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["POST","BK4212","SNGX","BK4139"],"gpt_icon":0},{"id":"2488967302","title":"Hybryte™ Clinical Results Demonstrate Continued Improvement Post-Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2488967302","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488967302?lang=en_us&edition=fundamental","pubTime":"2024-12-02 20:30","pubTimestamp":1733142643,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241202:nFWN3N30UQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SNGX","BK4139"],"gpt_icon":0},{"id":"2488675853","title":"Soligenix Inc: Hybryte Was Well Tolerated in All Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2488675853","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488675853?lang=en_us&edition=fundamental","pubTime":"2024-12-02 20:30","pubTimestamp":1733142643,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241202:nFWN3N30UQ:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","SNGX"],"gpt_icon":0},{"id":"2488673000","title":"Soligenix: 1 of 5 Patients Receiving Valchlor Had to Be Withdrawn From Trial Due to a Clinically Significant Allergic Contact Dermatitis","url":"https://stock-news.laohu8.com/highlight/detail?id=2488673000","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488673000?lang=en_us&edition=fundamental","pubTime":"2024-12-02 20:30","pubTimestamp":1733142643,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241202:nFWN3N30UQ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SNGX","BK4139"],"gpt_icon":0},{"id":"2486828233","title":"DealFlow Events Unveils First Wave of Companies for The Microcap Conference in January 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2486828233","media":"ACCESSWIRE","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486828233?lang=en_us&edition=fundamental","pubTime":"2024-11-27 20:00","pubTimestamp":1732708800,"startTime":"0","endTime":"0","summary":"ATLANTIC CITY, NJ / ACCESSWIRE / November 27, 2024 / DealFlow Events is pleased to announce the initial lineup of companies participating in The Microcap Conference, set for January 28-30 in Atlantic City, NJ. Now in its second year, the event is a key gathering for microcap and small-cap investors, offering a platform for investment and collaboration.Hosted at the Borgata Hotel & Casino, the conference provides executives of public growth companies an opportunity to engage with investors in meaningful discussions. Attendees include seasoned executives, institutional investors, high-net-worth individuals, hedge funds, and others.The event features company presentations, one-on-one meetings, keynote addresses, panel discussions, and networking opportunities. Executive teams from growth companies across sectors such as financial services, healthcare, energy, and technology are confirmed. The conference will host more than 100 companies and 1,500 attendees in the Borgata's main 30,000 sq.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/dealflow-events-unveils-first-wave-120000736.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4141","FUFUW","SJ","MYPS","QID","NQmain","SUUN","ABLLL","BK4173","ALCO","BETRW","ACXP","ABEO","MNQmain","FUFU","BK4563","EEIQ","PSQ","PERF","BK4539","WISA","BETR","BK4023","ALTS",".IXIC","BK4097","SRTS","THAR","BK4204","SQQQ","TMC","IPA","TQQQ","BK4082","ABLLW","BK4129","ACU","ASNS","BK4085","BK4229","SNGX","BK4108","ABL","BK4020","BK4121","BK4139","BK4189","DUOT","BK4168","QLD"],"gpt_icon":1},{"id":"2484945385","title":"BRIEF-Soligenix Announces Formation Of European Medical Advisory Board For Cutaneous T-Cell Lymphoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2484945385","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484945385?lang=en_us&edition=fundamental","pubTime":"2024-11-19 20:39","pubTimestamp":1732019982,"startTime":"0","endTime":"0","summary":"Nov 19 (Reuters) - Soligenix Inc   :   * SOLIGENIX ANNOUNCES FORMATION OF EUROPEAN MEDICAL ADVISORY BOARD FOR CUTANEOUS T-CELL LYMPHOMASource text:    Further company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SNGX","BK4139"],"gpt_icon":0},{"id":"2484297945","title":"Soligenix forms European Medical Advisory Board","url":"https://stock-news.laohu8.com/highlight/detail?id=2484297945","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484297945?lang=en_us&edition=fundamental","pubTime":"2024-11-19 20:36","pubTimestamp":1732019781,"startTime":"0","endTime":"0","summary":"Soligenix (SNGX) announced the formation of a European Medical Advisory Board to provide additional medical/clinical strategic guidance to the comp...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/soligenix-forms-european-medical-advisory-board?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/soligenix-forms-european-medical-advisory-board?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SNGX","BK4139"],"gpt_icon":0},{"id":"2484394316","title":"Soligenix Announces Formation of European Medical Advisory Board for Cutaneous T-Cell Lymphoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2484394316","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484394316?lang=en_us&edition=fundamental","pubTime":"2024-11-19 20:30","pubTimestamp":1732019405,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241119:nTUAC1F44:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SNGX","BK4139"],"gpt_icon":0},{"id":"2483397392","title":"Soligenix Third Quarter 2024 Earnings: US$0.78 loss per share (vs US$2.56 loss in 3Q 2023)","url":"https://stock-news.laohu8.com/highlight/detail?id=2483397392","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483397392?lang=en_us&edition=fundamental","pubTime":"2024-11-15 02:36","pubTimestamp":1731609360,"startTime":"0","endTime":"0","summary":"Soligenix ( NASDAQ:SNGX ) Third Quarter 2024 Results Key Financial Results Net loss: US$1.72m (loss widened by 3.4...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-sngx/soligenix/news/soligenix-third-quarter-2024-earnings-us078-loss-per-share-v","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["SNGX"],"gpt_icon":0},{"id":"2483871338","title":"Soligenix initiates Phase 2 clinical trial of SGX945 in Behcet’s Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2483871338","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483871338?lang=en_us&edition=fundamental","pubTime":"2024-11-14 20:21","pubTimestamp":1731586880,"startTime":"0","endTime":"0","summary":"Soligenix (SNGX) has opened patient enrollment for its Phase 2 study evaluating SGX945 – dusquetide – in the treatment of Behcet’s Disease. Soligen...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/soligenix-initiates-phase-2-clinical-trial-of-sgx945-in-behcets-disease?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/soligenix-initiates-phase-2-clinical-trial-of-sgx945-in-behcets-disease?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SNGX","BK4139"],"gpt_icon":0},{"id":"2483872972","title":"Soligenix Kickstarts Dusquetide Mid-Stage Study For Patients With Inflamed Blood Vessels","url":"https://stock-news.laohu8.com/highlight/detail?id=2483872972","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483872972?lang=en_us&edition=fundamental","pubTime":"2024-11-14 20:15","pubTimestamp":1731586538,"startTime":"0","endTime":"0","summary":"On Thursday, Soligenix Inc.  opened patient enrollment for its DUS-AUBD-01 Phase 2 study evaluating SGX945  for Behet's Disease, an inflammatory disorder of the blood vessels .The company looks forward to completing enrollment and announcing study results in the first half of 2025.The pilot clinical trial of SGX945 will be an open-label study that will enroll approximately 25 patients aged 18 years or older with mild to moderate Behet's Disease and active oral and/or genital ulcers.Patients will receive SGX945 as a twice-weekly 4-minute intravenous  infusion for 4 weeks, followed by 4 weeks of follow-up.Efficacy endpoints will include the extent of lesion clearance, timeline to lesion clearance, and patient reported quality of life assessments.Dusquetide, the active ingredient in SGX945  and SGX942 , is an innate defense regulator , a new class of short, synthetic peptides.This article Soligenix Kickstarts Dusquetide Mid-Stage Study For Patients With Inflamed Blood Vessels originally a","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/m3pJByKmKciqBrF0sjS0_w--~B/aD01NTM7dz05ODM7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/Benzinga/2a6a14918d976161a7b2d5e80971712a","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/m3pJByKmKciqBrF0sjS0_w--~B/aD01NTM7dz05ODM7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/Benzinga/2a6a14918d976161a7b2d5e80971712a"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/soligenix-kickstarts-dusquetide-mid-stage-121538559.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4168","BK4139","SSI","SNGX","IDR"],"gpt_icon":0},{"id":"2483879130","title":"Soligenix Initiates a Phase 2 Clinical Trial of Sgx945 (Dusquetide) for the Treatment of BehÇEt's Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2483879130","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483879130?lang=en_us&edition=fundamental","pubTime":"2024-11-14 20:15","pubTimestamp":1731586503,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241114:nTUA10NZMT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SNGX","BK4139"],"gpt_icon":0},{"id":"2482768773","title":"SNGX: Phase 3 CTCL Trial to Initiate Before End of 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2482768773","media":"Zacks Small Cap Research","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482768773?lang=en_us&edition=fundamental","pubTime":"2024-11-11 22:00","pubTimestamp":1731333600,"startTime":"0","endTime":"0","summary":"Soligenix, Inc.  is on track to initiate a confirmatory Phase 3 trial of HyBryte for the treatment of cutaneous T cell lymphoma  before the end of 2024. The FLASH2 trial will be very similar in design to the Phase 3 FLASH trial, as shown in the following figure, which provides a comparison between the two studies. This similarity in design increases our confidence in a positive outcome for the FLASH2 trial. With the trial expected to begin enrollment prior to the end of 2024, we anticipate topline results in the second half of 2026. After reaching agreement with the European Medicines Agency  on the key design elements of the FLASH2 trial, the company is continuing discussions with the U.S. Food and Drug Administration  on an appropriate study design as the agency has expressed a preference for a longer duration comparative study over a placebo-controlled trial.","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/z_GjVNtFw1obaLZ0EQ0qmg--~B/aD03Njg7dz0xMzQ4O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/scr.zacks.com/2e0dc8c54e24777f006711b43b2bc1ae","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/z_GjVNtFw1obaLZ0EQ0qmg--~B/aD03Njg7dz0xMzQ4O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/scr.zacks.com/2e0dc8c54e24777f006711b43b2bc1ae"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/sngx-phase-3-ctcl-trial-140000389.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["SNGX","BK4139"],"gpt_icon":0},{"id":"2482261103","title":"Soligenix Third Quarter 2024 Earnings: US$0.78 loss per share (vs US$2.56 loss in 3Q 2023)","url":"https://stock-news.laohu8.com/highlight/detail?id=2482261103","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482261103?lang=en_us&edition=fundamental","pubTime":"2024-11-10 22:12","pubTimestamp":1731247938,"startTime":"0","endTime":"0","summary":"NasdaqCM:SNGX Earnings and Revenue History November 10th 2024. All figures shown in the chart above are for the trailing 12 month  period. Looking ahead, revenue is forecast to grow 36% p.a. on average during the next 3 years, compared to a 21% growth forecast for the Biotechs industry in the US.The company's shares are down 9.3% from a week ago.It is worth noting though that we have found 6 warning signs for Soligenix (5 are potentially serious!) that you need to take into consideration.","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/5Vpve0Pc2F3m_L3fs2p_dQ--~B/aD02MzY7dz05NDU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/78a8c60a6283aea0450523395306d38c","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/5Vpve0Pc2F3m_L3fs2p_dQ--~B/aD02MzY7dz05NDU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/78a8c60a6283aea0450523395306d38c"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/soligenix-third-quarter-2024-earnings-141218493.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["SNGX"],"gpt_icon":0},{"id":"2482148485","title":"Soligenix Inc  expected to post a loss of $1.09 a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2482148485","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482148485?lang=en_us&edition=fundamental","pubTime":"2024-11-09 00:03","pubTimestamp":1731081798,"startTime":"0","endTime":"0","summary":"Soligenix Inc  expected to post a loss of $1.09 a share - Earnings Preview Soligenix Inc SNGX.OQ SNGX.O is expected to show a rise in quarterly revenue when it reports  results on November 8 for the p","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241108:nL8N3MF2BE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SNGX"],"gpt_icon":0},{"id":"2481745331","title":"Soligenix Qtrly Share Loss $0.78","url":"https://stock-news.laohu8.com/highlight/detail?id=2481745331","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481745331?lang=en_us&edition=fundamental","pubTime":"2024-11-08 20:30","pubTimestamp":1731069002,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241108:nTUA8HTBJJ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","SNGX"],"gpt_icon":0},{"id":"2481171142","title":"Soligenix Announces Recent Accomplishments and Third Quarter 2024 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2481171142","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481171142?lang=en_us&edition=fundamental","pubTime":"2024-11-08 20:30","pubTimestamp":1731069002,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241108:nTUA8HTBJJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SNGX","BK4139"],"gpt_icon":0},{"id":"2481174389","title":"Press Release: Soligenix Announces Recent Accomplishments And Third Quarter 2024 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2481174389","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481174389?lang=en_us&edition=fundamental","pubTime":"2024-11-08 20:30","pubTimestamp":1731069000,"startTime":"0","endTime":"0","summary":"PRINCETON, N.J., Nov. 8, 2024 /PRNewswire/ -- Soligenix, Inc.  , a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today its recent accomplishments and financial results for the quarter ended September 30, 2024.\"We remain focused on multiple clinical activities and upcoming milestones, including the initiation of our confirmatory Phase 3 placebo-controlled study evaluating HyBryte  in the treatment of early-stage cutaneous T-cell lymphoma  before yearend,\" stated Christopher J. Schaber, PhD, President and Chief Executive Officer of Soligenix. Additionally, we are set to initiate a Phase 2 study for SGX945  in Behet's disease shortly, with top-line results expected in the first half of 2025, which will be accompanied by data readout from our ongoing SGX302  Phase 2 study in mild-to-moderate psoriasis in the first half as well.\". Dr. Schaber continued, \"With approximately $9.8 m","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","IDR","BK4099","SNGX","R","TM","BK4139","03160","BK4232","BK4022","BK4555","BK4168","BK4588"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":2,"totalSize":43,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SNGX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-03-21","symbol":"SNGX","fiscalQuarterEnding":"2024/12","expectedEps":-0.95,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1742529600000,"reportTimeType":"pre","actualEps":-1.14},{"market":"US","date":"2024-11-08","symbol":"SNGX","fiscalQuarterEnding":"2024/09","expectedEps":-1.09,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1731042000000,"reportTimeType":"pre","actualEps":-0.78},{"market":"US","date":"2024-08-09","symbol":"SNGX","fiscalQuarterEnding":"2024/06","expectedEps":-2.11,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1723176000000,"reportTimeType":"pre","actualEps":-1.31},{"market":"US","date":"2024-06-06","symbol":"SNGX","defaultRemindTime":1717680600000,"type":"split","dateTimestamp":1717646400000,"forFactor":16,"toFactor":1,"ratio":16},{"market":"US","date":"2024-05-10","symbol":"SNGX","fiscalQuarterEnding":"2024/03","expectedEps":-0.2,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1715313600000,"reportTimeType":"pre","actualEps":-0.18}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SNGX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SNGX\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/SNGX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"SNGX","date":"2025-04-15","current":-0.748191,"percent":0.808597,"low":-5.464746,"twenty":-3.368231,"median":-1.703795,"eighty":-0.780869,"high":-0.277411,"avg":-1.985116,"sd":1.255673,"marketCap":6184981},"quantilePoints":[{"date":"2020-04-17","current":-4.022887,"twenty":-3.712662,"median":-2.965739,"eighty":-2.106354,"marketCap":37636488},{"date":"2020-04-24","current":-3.885117,"twenty":-3.712662,"median":-2.965739,"eighty":-2.106354,"marketCap":36347567},{"date":"2020-05-01","current":-4.215765,"twenty":-3.71974,"median":-2.965739,"eighty":-2.106354,"marketCap":39440977},{"date":"2020-05-08","current":-4.491305,"twenty":-3.744873,"median":-2.965739,"eighty":-2.106354,"marketCap":42018818},{"date":"2020-05-15","current":-2.72763,"twenty":-3.745836,"median":-2.963367,"eighty":-2.106354,"marketCap":41725374},{"date":"2020-05-22","current":-3.648423,"twenty":-3.745836,"median":-2.957629,"eighty":-2.106354,"marketCap":55811010},{"date":"2020-05-29","current":-3.318327,"twenty":-3.745836,"median":-2.957629,"eighty":-2.106354,"marketCap":50761441},{"date":"2020-06-05","current":-3.683169,"twenty":-3.745836,"median":-2.957629,"eighty":-2.106354,"marketCap":56342543},{"date":"2020-06-12","current":-3.300954,"twenty":-3.747347,"median":-2.957629,"eighty":-2.106354,"marketCap":50495674},{"date":"2020-06-19","current":-3.075099,"twenty":-3.747347,"median":-2.957629,"eighty":-2.106354,"marketCap":47040707},{"date":"2020-06-26","current":-3.631049,"twenty":-3.744873,"median":-2.957629,"eighty":-2.106354,"marketCap":55545243},{"date":"2020-07-02","current":-3.405194,"twenty":-3.729793,"median":-2.957629,"eighty":-2.106354,"marketCap":52090276},{"date":"2020-07-10","current":-3.526808,"twenty":-3.712662,"median":-2.957629,"eighty":-2.106354,"marketCap":53950642},{"date":"2020-07-17","current":-4.183339,"twenty":-3.710161,"median":-2.957629,"eighty":-2.106354,"marketCap":63993787},{"date":"2020-07-24","current":-4.164923,"twenty":-3.710161,"median":-2.957629,"eighty":-2.106354,"marketCap":63712077},{"date":"2020-07-31","current":-4.202786,"twenty":-3.71974,"median":-2.957629,"eighty":-2.106354,"marketCap":64291278},{"date":"2020-08-07","current":-4.278512,"twenty":-3.73529,"median":-2.958383,"eighty":-2.106354,"marketCap":65449680},{"date":"2020-08-14","current":-3.798616,"twenty":-3.745836,"median":-2.963367,"eighty":-2.106354,"marketCap":60589987},{"date":"2020-08-21","current":-4.041878,"twenty":-3.787557,"median":-2.963367,"eighty":-2.106354,"marketCap":64470134},{"date":"2020-08-28","current":-3.686342,"twenty":-3.798616,"median":-2.963367,"eighty":-2.106354,"marketCap":58799151},{"date":"2020-09-04","current":-3.368231,"twenty":-3.793641,"median":-2.963367,"eighty":-2.106354,"marketCap":53725112},{"date":"2020-09-11","current":-3.555355,"twenty":-3.793641,"median":-2.963367,"eighty":-2.106354,"marketCap":56709840},{"date":"2020-09-18","current":-3.742479,"twenty":-3.793641,"median":-2.963367,"eighty":-2.106354,"marketCap":59694570},{"date":"2020-09-25","current":-3.181107,"twenty":-3.792424,"median":-2.965739,"eighty":-2.107674,"marketCap":50740384},{"date":"2020-10-02","current":-3.255957,"twenty":-3.792424,"median":-2.974005,"eighty":-2.107674,"marketCap":51934274},{"date":"2020-10-09","current":-3.349519,"twenty":-3.792424,"median":-2.993101,"eighty":-2.107674,"marketCap":53426639},{"date":"2020-10-16","current":-3.349519,"twenty":-3.792424,"median":-2.996669,"eighty":-2.107674,"marketCap":53426639},{"date":"2020-10-23","current":-3.405656,"twenty":-3.792424,"median":-3.016006,"eighty":-2.107674,"marketCap":54322058},{"date":"2020-10-30","current":-3.181107,"twenty":-3.792424,"median":-3.02874,"eighty":-2.107674,"marketCap":50740384},{"date":"2020-11-06","current":-3.068833,"twenty":-3.792424,"median":-3.03163,"eighty":-2.107674,"marketCap":48949546},{"date":"2020-11-13","current":-3.576924,"twenty":-3.792424,"median":-3.032343,"eighty":-2.107674,"marketCap":53725112},{"date":"2020-11-20","current":-4.371797,"twenty":-3.807236,"median":-3.032343,"eighty":-2.107674,"marketCap":65664026},{"date":"2020-11-27","current":-4.332053,"twenty":-3.808915,"median":-3.032343,"eighty":-2.107674,"marketCap":65067080},{"date":"2020-12-04","current":-4.967951,"twenty":-3.822057,"median":-3.032343,"eighty":-2.113513,"marketCap":74618212},{"date":"2020-12-11","current":-4.570515,"twenty":-3.833505,"median":-3.035911,"eighty":-2.115839,"marketCap":68648754},{"date":"2020-12-18","current":-5.325643,"twenty":-3.84402,"median":-3.041386,"eighty":-2.116451,"marketCap":79990722},{"date":"2020-12-24","current":-2.662821,"twenty":-3.835838,"median":-3.035911,"eighty":-2.116451,"marketCap":39995360},{"date":"2020-12-31","current":-2.543591,"twenty":-3.825781,"median":-3.032517,"eighty":-2.116451,"marketCap":38204524},{"date":"2021-01-08","current":-2.821796,"twenty":-3.820118,"median":-3.031986,"eighty":-2.116451,"marketCap":42383144},{"date":"2021-01-15","current":-2.997624,"twenty":-3.820118,"median":-3.02874,"eighty":-2.116451,"marketCap":45024063},{"date":"2021-01-22","current":-3.605533,"twenty":-3.820118,"median":-3.02874,"eighty":-2.116451,"marketCap":54154817},{"date":"2021-01-29","current":-3.249173,"twenty":-3.822057,"median":-3.02874,"eighty":-2.116451,"marketCap":48802306},{"date":"2021-02-05","current":-3.458797,"twenty":-3.822057,"median":-3.02874,"eighty":-2.116451,"marketCap":51950841},{"date":"2021-02-12","current":-4.485954,"twenty":-3.822137,"median":-3.02874,"eighty":-2.116451,"marketCap":67378666},{"date":"2021-02-19","current":-3.982857,"twenty":-3.833505,"median":-3.030551,"eighty":-2.116451,"marketCap":59822181},{"date":"2021-02-26","current":-3.458797,"twenty":-3.833505,"median":-3.03163,"eighty":-2.116451,"marketCap":51950841},{"date":"2021-03-05","current":-3.207248,"twenty":-3.835264,"median":-3.031519,"eighty":-2.11619,"marketCap":48172598},{"date":"2021-03-12","current":-3.75227,"twenty":-3.835264,"median":-3.03243,"eighty":-2.11619,"marketCap":56358791},{"date":"2021-03-19","current":-3.75227,"twenty":-3.83612,"median":-3.040991,"eighty":-2.11619,"marketCap":56358791},{"date":"2021-03-26","current":-3.270135,"twenty":-3.835838,"median":-3.042299,"eighty":-2.116451,"marketCap":49117159},{"date":"2021-04-01","current":-3.529516,"twenty":-3.826467,"median":-3.042299,"eighty":-2.116451,"marketCap":62431916},{"date":"2021-04-09","current":-3.41639,"twenty":-3.822157,"median":-3.042299,"eighty":-2.11619,"marketCap":60430892},{"date":"2021-04-16","current":-2.963888,"twenty":-3.822157,"median":-3.041843,"eighty":-2.11619,"marketCap":52426802},{"date":"2021-04-23","current":-3.212764,"twenty":-3.822057,"median":-3.040991,"eighty":-2.11619,"marketCap":56829052},{"date":"2021-04-30","current":-3.258014,"twenty":-3.822057,"median":-3.040991,"eighty":-2.11619,"marketCap":57629461},{"date":"2021-05-07","current":-2.896013,"twenty":-3.808915,"median":-3.033651,"eighty":-2.11619,"marketCap":51226187},{"date":"2021-05-14","current":-2.013634,"twenty":-3.807849,"median":-3.030979,"eighty":-2.11619,"marketCap":35618208},{"date":"2021-05-21","current":-3.342664,"twenty":-3.807849,"median":-3.034785,"eighty":-2.11619,"marketCap":41681899},{"date":"2021-05-28","current":-3.278382,"twenty":-3.807849,"median":-3.042299,"eighty":-2.11619,"marketCap":40880324},{"date":"2021-06-04","current":-3.471227,"twenty":-3.807849,"median":-3.047644,"eighty":-2.11619,"marketCap":43285047},{"date":"2021-06-11","current":-3.792638,"twenty":-3.808915,"median":-3.051016,"eighty":-2.11619,"marketCap":47292924},{"date":"2021-06-18","current":-3.599792,"twenty":-3.815158,"median":-3.058506,"eighty":-2.11619,"marketCap":44888198},{"date":"2021-06-25","current":-3.696215,"twenty":-3.815158,"median":-3.073824,"eighty":-2.11619,"marketCap":46090561},{"date":"2021-07-02","current":-3.342664,"twenty":-3.814599,"median":-3.085535,"eighty":-2.11619,"marketCap":41681899},{"date":"2021-07-09","current":-3.406946,"twenty":-3.820677,"median":-3.087545,"eighty":-2.11619,"marketCap":42483474},{"date":"2021-07-16","current":-3.149818,"twenty":-3.820677,"median":-3.091406,"eighty":-2.11619,"marketCap":39277173},{"date":"2021-07-23","current":-3.10032,"twenty":-3.820677,"median":-3.101159,"eighty":-2.11619,"marketCap":38659960},{"date":"2021-07-30","current":-3.063037,"twenty":-3.820677,"median":-3.120558,"eighty":-2.11619,"marketCap":38195046},{"date":"2021-08-06","current":-3.2141,"twenty":-3.820677,"median":-3.123123,"eighty":-2.11619,"marketCap":40078748},{"date":"2021-08-13","current":-3.271976,"twenty":-3.820677,"median":-3.12497,"eighty":-2.116451,"marketCap":37922108},{"date":"2021-08-20","current":-3.183049,"twenty":-3.820677,"median":-3.127219,"eighty":-2.128852,"marketCap":36891443},{"date":"2021-08-27","current":-3.529416,"twenty":-3.819297,"median":-3.140414,"eighty":-2.139444,"marketCap":40905829},{"date":"2021-09-03","current":-3.806233,"twenty":-3.819297,"median":-3.149818,"eighty":-2.140169,"marketCap":44114128},{"date":"2021-09-10","current":-4.013846,"twenty":-3.822057,"median":-3.152361,"eighty":-2.145333,"marketCap":46520354},{"date":"2021-09-17","current":-3.737029,"twenty":-3.822117,"median":-3.16435,"eighty":-2.145333,"marketCap":43312052},{"date":"2021-09-24","current":-3.546717,"twenty":-3.822117,"median":-3.180179,"eighty":-2.145333,"marketCap":41106347},{"date":"2021-10-01","current":-3.633222,"twenty":-3.822117,"median":-3.181533,"eighty":-2.145333,"marketCap":42108942},{"date":"2021-10-08","current":-3.59862,"twenty":-3.822117,"median":-3.189617,"eighty":-2.145333,"marketCap":41707904},{"date":"2021-10-15","current":-3.806233,"twenty":-3.822117,"median":-3.197852,"eighty":-2.150499,"marketCap":44114128},{"date":"2021-10-22","current":-3.494814,"twenty":-3.822117,"median":-3.211097,"eighty":-2.154035,"marketCap":40504791},{"date":"2021-10-29","current":-3.494814,"twenty":-3.822117,"median":-3.2141,"eighty":-2.161849,"marketCap":40504791},{"date":"2021-11-05","current":-3.42561,"twenty":-3.822117,"median":-3.220267,"eighty":-2.162699,"marketCap":39702715},{"date":"2021-11-12","current":-2.916544,"twenty":-3.822117,"median":-3.222002,"eighty":-2.170406,"marketCap":39044830},{"date":"2021-11-19","current":-2.741366,"twenty":-3.822117,"median":-3.218265,"eighty":-2.170406,"marketCap":36699653},{"date":"2021-11-26","current":-2.875872,"twenty":-3.822117,"median":-3.216049,"eighty":-2.170406,"marketCap":38500338},{"date":"2021-12-03","current":-2.562024,"twenty":-3.822117,"median":-3.2141,"eighty":-2.170406,"marketCap":34298742},{"date":"2021-12-10","current":-2.446092,"twenty":-3.822117,"median":-3.2141,"eighty":-2.170406,"marketCap":32746723},{"date":"2021-12-17","current":-2.394211,"twenty":-3.822117,"median":-3.211931,"eighty":-2.170406,"marketCap":32052174},{"date":"2021-12-23","current":-2.458582,"twenty":-3.822117,"median":-3.203637,"eighty":-2.170406,"marketCap":32913930},{"date":"2021-12-31","current":-2.114631,"twenty":-3.822117,"median":-3.191039,"eighty":-2.169084,"marketCap":28309324},{"date":"2022-01-07","current":-2.217909,"twenty":-3.822097,"median":-3.181959,"eighty":-2.166201,"marketCap":29691947},{"date":"2022-01-14","current":-2.069155,"twenty":-3.813481,"median":-3.181107,"eighty":-2.161849,"marketCap":27700521},{"date":"2022-01-21","current":-2.036489,"twenty":-3.810294,"median":-3.1662,"eighty":-2.161849,"marketCap":27263212},{"date":"2022-01-28","current":-1.97436,"twenty":-3.809605,"median":-3.158329,"eighty":-2.15359,"marketCap":26431467},{"date":"2022-02-04","current":-1.986209,"twenty":-3.809605,"median":-3.149818,"eighty":-2.148285,"marketCap":26590099},{"date":"2022-02-11","current":-2.014712,"twenty":-3.809605,"median":-3.144477,"eighty":-2.14007,"marketCap":26971673},{"date":"2022-02-18","current":-2.17772,"twenty":-3.809605,"median":-3.132783,"eighty":-2.139444,"marketCap":29153928},{"date":"2022-02-25","current":-2.306142,"twenty":-3.809605,"median":-3.129679,"eighty":-2.139444,"marketCap":30873154},{"date":"2022-03-04","current":-2.145054,"twenty":-3.809605,"median":-3.129679,"eighty":-2.138219,"marketCap":28716619},{"date":"2022-03-11","current":-2.312226,"twenty":-3.809605,"median":-3.124184,"eighty":-2.138219,"marketCap":30954613},{"date":"2022-03-18","current":-2.222556,"twenty":-3.806233,"median":-3.11997,"eighty":-2.138219,"marketCap":29754157},{"date":"2022-03-25","current":-2.309344,"twenty":-3.806233,"median":-3.105034,"eighty":-2.138219,"marketCap":30916027},{"date":"2022-04-01","current":-2.532554,"twenty":-3.806233,"median":-3.105034,"eighty":-2.139763,"marketCap":31786020},{"date":"2022-04-08","current":-2.529132,"twenty":-3.806233,"median":-3.105034,"eighty":-2.14463,"marketCap":31743066},{"date":"2022-04-14","current":-2.481219,"twenty":-3.806233,"median":-3.105034,"eighty":-2.150636,"marketCap":31141708},{"date":"2022-04-22","current":-2.102362,"twenty":-3.806233,"median":-3.105034,"eighty":-2.152006,"marketCap":26386692},{"date":"2022-04-29","current":-1.80975,"twenty":-3.806233,"median":-3.105034,"eighty":-2.14463,"marketCap":22714119},{"date":"2022-05-06","current":-1.772104,"twenty":-3.806233,"median":-3.105034,"eighty":-2.142794,"marketCap":22241624},{"date":"2022-05-13","current":-1.178605,"twenty":-3.806233,"median":-3.100739,"eighty":-2.140196,"marketCap":17133992},{"date":"2022-05-20","current":-1.543144,"twenty":-3.806233,"median":-3.091406,"eighty":-2.139444,"marketCap":22433476},{"date":"2022-05-27","current":-1.77383,"twenty":-3.806233,"median":-3.089475,"eighty":-2.129342,"marketCap":25787088},{"date":"2022-06-03","current":-1.514419,"twenty":-3.806233,"median":-3.087545,"eighty":-2.119815,"marketCap":22015888},{"date":"2022-06-10","current":-1.776792,"twenty":-3.806233,"median":-3.087545,"eighty":-2.115527,"marketCap":25830138},{"date":"2022-06-17","current":-1.687952,"twenty":-3.806233,"median":-3.087545,"eighty":-2.100887,"marketCap":24538630},{"date":"2022-06-24","current":-1.617473,"twenty":-3.806233,"median":-3.087545,"eighty":-2.092935,"marketCap":23514034},{"date":"2022-07-01","current":-1.719934,"twenty":-3.806233,"median":-3.087545,"eighty":-2.086976,"marketCap":25003573},{"date":"2022-07-08","current":-1.762281,"twenty":-3.806233,"median":-3.087545,"eighty":-2.078536,"marketCap":25619192},{"date":"2022-07-15","current":-2.025543,"twenty":-3.806233,"median":-3.087545,"eighty":-2.0727,"marketCap":29446357},{"date":"2022-07-22","current":-2.259783,"twenty":-3.806233,"median":-3.077014,"eighty":-2.0727,"marketCap":32851632},{"date":"2022-07-29","current":-2.592339,"twenty":-3.806233,"median":-3.070415,"eighty":-2.0727,"marketCap":37686173},{"date":"2022-08-05","current":-2.679994,"twenty":-3.806233,"median":-3.070415,"eighty":-2.0727,"marketCap":38960460},{"date":"2022-08-12","current":-2.539174,"twenty":-3.806233,"median":-3.068833,"eighty":-2.0727,"marketCap":38156702},{"date":"2022-08-19","current":-2.380834,"twenty":-3.793261,"median":-3.057725,"eighty":-2.0727,"marketCap":35777295},{"date":"2022-08-26","current":-2.280438,"twenty":-3.77381,"median":-3.037933,"eighty":-2.0727,"marketCap":34268616},{"date":"2022-09-02","current":-2.065302,"twenty":-3.75227,"median":-3.012696,"eighty":-2.072608,"marketCap":31035726},{"date":"2022-09-09","current":-1.986419,"twenty":-3.744873,"median":-2.99389,"eighty":-2.068643,"marketCap":29850333},{"date":"2022-09-16","current":-1.921878,"twenty":-3.736351,"median":-2.972351,"eighty":-2.06071,"marketCap":28880466},{"date":"2022-09-23","current":-1.455464,"twenty":-3.71974,"median":-2.963888,"eighty":-2.050413,"marketCap":21871566},{"date":"2022-09-30","current":-1.252663,"twenty":-3.703324,"median":-2.929273,"eighty":-2.049272,"marketCap":18824029},{"date":"2022-10-07","current":-1.641628,"twenty":-3.69525,"median":-2.907735,"eighty":-2.046565,"marketCap":24669091},{"date":"2022-10-14","current":-1.686663,"twenty":-3.686342,"median":-2.894033,"eighty":-2.042346,"marketCap":25345843},{"date":"2022-10-21","current":-1.804558,"twenty":-3.668494,"median":-2.865205,"eighty":-2.037717,"marketCap":27117466},{"date":"2022-10-28","current":-2.007933,"twenty":-3.667825,"median":-2.841668,"eighty":-2.029514,"marketCap":30173622},{"date":"2022-11-04","current":-1.893481,"twenty":-3.66653,"median":-2.8149,"eighty":-2.026959,"marketCap":28453728},{"date":"2022-11-11","current":-2.05165,"twenty":-3.663597,"median":-2.797124,"eighty":-2.021049,"marketCap":30259092},{"date":"2022-11-18","current":-1.905104,"twenty":-3.648917,"median":-2.778014,"eighty":-2.01711,"marketCap":28097730},{"date":"2022-11-25","current":-1.699939,"twenty":-3.641768,"median":-2.743928,"eighty":-2.014281,"marketCap":25071819},{"date":"2022-12-02","current":-1.64132,"twenty":-3.633222,"median":-2.735277,"eighty":-2.004814,"marketCap":24207273},{"date":"2022-12-09","current":-1.533755,"twenty":-3.633222,"median":-2.711283,"eighty":-1.996265,"marketCap":22620834},{"date":"2022-12-16","current":-1.846485,"twenty":-3.633222,"median":-2.682693,"eighty":-1.984215,"marketCap":27233184},{"date":"2022-12-23","current":-1.891329,"twenty":-3.633222,"median":-2.662821,"eighty":-1.97859,"marketCap":27894562},{"date":"2022-12-30","current":-1.32478,"twenty":-3.633222,"median":-2.64295,"eighty":-1.974296,"marketCap":19538728},{"date":"2023-01-06","current":-1.410357,"twenty":-3.630477,"median":-2.626074,"eighty":-1.970255,"marketCap":20800882},{"date":"2023-01-13","current":-1.377155,"twenty":-3.619207,"median":-2.596781,"eighty":-1.964148,"marketCap":20311194},{"date":"2023-01-20","current":-1.469416,"twenty":-3.619207,"median":-2.584653,"eighty":-1.961265,"marketCap":21671919},{"date":"2023-01-27","current":-1.409182,"twenty":-3.619207,"median":-2.562024,"eighty":-1.955717,"marketCap":20783547},{"date":"2023-02-03","current":-1.351886,"twenty":-3.615611,"median":-2.546439,"eighty":-1.950333,"marketCap":19938511},{"date":"2023-02-10","current":-1.047974,"twenty":-3.615611,"median":-2.539174,"eighty":-1.93629,"marketCap":15456214},{"date":"2023-02-17","current":-0.812914,"twenty":-3.615611,"median":-2.519549,"eighty":-1.920521,"marketCap":11989399},{"date":"2023-02-24","current":-0.744355,"twenty":-3.615611,"median":-2.50894,"eighty":-1.916691,"marketCap":10978245},{"date":"2023-03-03","current":-0.579814,"twenty":-3.615611,"median":-2.50315,"eighty":-1.905104,"marketCap":8551475},{"date":"2023-03-10","current":-0.628784,"twenty":-3.615611,"median":-2.498294,"eighty":-1.893481,"marketCap":9273728},{"date":"2023-03-17","current":-0.45249,"twenty":-3.615611,"median":-2.494874,"eighty":-1.873469,"marketCap":6673617},{"date":"2023-03-24","current":-0.360425,"twenty":-3.615611,"median":-2.490459,"eighty":-1.864593,"marketCap":5315782},{"date":"2023-03-31","current":-0.385889,"twenty":-3.614644,"median":-2.487664,"eighty":-1.852184,"marketCap":5691353},{"date":"2023-04-06","current":-0.368498,"twenty":-3.614644,"median":-2.487664,"eighty":-1.838884,"marketCap":5084661},{"date":"2023-04-14","current":-0.343373,"twenty":-3.615611,"median":-2.488267,"eighty":-1.81823,"marketCap":4737979},{"date":"2023-04-21","current":-0.311554,"twenty":-3.615611,"median":-2.488267,"eighty":-1.806924,"marketCap":4298921},{"date":"2023-04-28","current":-0.311554,"twenty":-3.615611,"median":-2.488267,"eighty":-1.796476,"marketCap":4298921},{"date":"2023-05-05","current":-0.486536,"twenty":-3.615611,"median":-2.488267,"eighty":-1.780665,"marketCap":6713384},{"date":"2023-05-12","current":-0.530952,"twenty":-3.615611,"median":-2.488267,"eighty":-1.774785,"marketCap":7326252},{"date":"2023-05-19","current":-0.450777,"twenty":-3.615611,"median":-2.488267,"eighty":-1.773356,"marketCap":4731101},{"date":"2023-05-26","current":-0.548639,"twenty":-3.615611,"median":-2.488267,"eighty":-1.762981,"marketCap":5758198},{"date":"2023-06-02","current":-0.556758,"twenty":-3.615611,"median":-2.488267,"eighty":-1.761231,"marketCap":5843414},{"date":"2023-06-09","current":-0.568435,"twenty":-3.615611,"median":-2.488267,"eighty":-1.758431,"marketCap":5965964},{"date":"2023-06-16","current":-0.553201,"twenty":-3.615611,"median":-2.488267,"eighty":-1.753075,"marketCap":5806081},{"date":"2023-06-23","current":-0.549104,"twenty":-3.616579,"median":-2.489363,"eighty":-1.755221,"marketCap":5763076},{"date":"2023-06-30","current":-0.549025,"twenty":-3.617546,"median":-2.490459,"eighty":-1.751843,"marketCap":5762256},{"date":"2023-07-07","current":-0.561243,"twenty":-3.617546,"median":-2.490459,"eighty":-1.719975,"marketCap":5890486},{"date":"2023-07-14","current":-0.534333,"twenty":-3.617546,"median":-2.490459,"eighty":-1.701031,"marketCap":5608055},{"date":"2023-07-21","current":-0.517398,"twenty":-3.617546,"median":-2.488267,"eighty":-1.696019,"marketCap":5430317},{"date":"2023-07-28","current":-0.487163,"twenty":-3.617546,"median":-2.48706,"eighty":-1.691433,"marketCap":5112988},{"date":"2023-08-04","current":-0.458552,"twenty":-3.617546,"median":-2.471478,"eighty":-1.68556,"marketCap":4812701},{"date":"2023-08-11","current":-0.492307,"twenty":-3.605533,"median":-2.464449,"eighty":-1.673383,"marketCap":5166973},{"date":"2023-08-18","current":-0.451047,"twenty":-3.604385,"median":-2.451581,"eighty":-1.658517,"marketCap":4733931},{"date":"2023-08-25","current":-0.474846,"twenty":-3.599792,"median":-2.429294,"eighty":-1.650503,"marketCap":4615829},{"date":"2023-09-01","current":-0.455119,"twenty":-3.59581,"median":-2.407007,"eighty":-1.641321,"marketCap":4424070},{"date":"2023-09-08","current":-0.515598,"twenty":-3.574766,"median":-2.401897,"eighty":-1.635487,"marketCap":5011970},{"date":"2023-09-15","current":-0.457243,"twenty":-3.566924,"median":-2.38362,"eighty":-1.627894,"marketCap":4444715},{"date":"2023-09-22","current":-0.50771,"twenty":-3.560315,"median":-2.374811,"eighty":-1.617598,"marketCap":4935296},{"date":"2023-09-29","current":-0.546143,"twenty":-3.551056,"median":-2.338167,"eighty":-1.605284,"marketCap":5308884},{"date":"2023-10-06","current":-0.576484,"twenty":-3.535509,"median":-2.330801,"eighty":-1.598066,"marketCap":5603822},{"date":"2023-10-13","current":-0.56637,"twenty":-3.529416,"median":-2.317858,"eighty":-1.582702,"marketCap":5505509},{"date":"2023-10-20","current":-0.529961,"twenty":-3.529416,"median":-2.309344,"eighty":-1.582674,"marketCap":5151583},{"date":"2023-10-27","current":-0.515296,"twenty":-3.529416,"median":-2.303676,"eighty":-1.573299,"marketCap":5009030},{"date":"2023-11-03","current":-0.488595,"twenty":-3.529416,"median":-2.295319,"eighty":-1.555321,"marketCap":4749485},{"date":"2023-11-10","current":-0.420732,"twenty":-3.529416,"median":-2.279706,"eighty":-1.52544,"marketCap":4089807},{"date":"2023-11-17","current":-0.49227,"twenty":-3.529416,"median":-2.266533,"eighty":-1.497359,"marketCap":3974781},{"date":"2023-11-24","current":-0.519915,"twenty":-3.529416,"median":-2.255719,"eighty":-1.484111,"marketCap":4197997},{"date":"2023-12-01","current":-1.259878,"twenty":-3.529416,"median":-2.246954,"eighty":-1.471408,"marketCap":10172748},{"date":"2023-12-08","current":-0.944716,"twenty":-3.529416,"median":-2.243626,"eighty":-1.458806,"marketCap":7628004},{"date":"2023-12-15","current":-0.760271,"twenty":-3.529416,"median":-2.242091,"eighty":-1.44978,"marketCap":6138727},{"date":"2023-12-22","current":-0.781479,"twenty":-3.529416,"median":-2.242091,"eighty":-1.42203,"marketCap":6309968},{"date":"2023-12-29","current":-0.878907,"twenty":-3.529416,"median":-2.242858,"eighty":-1.409887,"marketCap":7096639},{"date":"2024-01-05","current":-1.166178,"twenty":-3.529416,"median":-2.243626,"eighty":-1.402478,"marketCap":9416175},{"date":"2024-01-12","current":-1.113479,"twenty":-3.529416,"median":-2.241771,"eighty":-1.377273,"marketCap":8990667},{"date":"2024-01-19","current":-0.798188,"twenty":-3.529416,"median":-2.240902,"eighty":-1.367144,"marketCap":6444885},{"date":"2024-01-26","current":-0.76477,"twenty":-3.529416,"median":-2.232464,"eighty":-1.350711,"marketCap":6175051},{"date":"2024-02-02","current":-0.861041,"twenty":-3.529416,"median":-2.232464,"eighty":-1.323591,"marketCap":6952381},{"date":"2024-02-09","current":-0.832892,"twenty":-3.529416,"median":-2.232464,"eighty":-1.284479,"marketCap":6725098},{"date":"2024-02-16","current":-0.935719,"twenty":-3.529416,"median":-2.232464,"eighty":-1.19338,"marketCap":7555357},{"date":"2024-02-23","current":-0.96014,"twenty":-3.529416,"median":-2.232464,"eighty":-1.170061,"marketCap":7752543},{"date":"2024-03-01","current":-0.937004,"twenty":-3.529416,"median":-2.232314,"eighty":-1.094071,"marketCap":7565735},{"date":"2024-03-08","current":-1.015409,"twenty":-3.529416,"median":-2.232314,"eighty":-1.04266,"marketCap":8198808},{"date":"2024-03-15","current":-0.818497,"twenty":-3.529416,"median":-2.232314,"eighty":-0.985743,"marketCap":6608861},{"date":"2024-03-22","current":-1.096879,"twenty":-3.529416,"median":-2.231918,"eighty":-0.985743,"marketCap":6735639},{"date":"2024-03-28","current":-1.040493,"twenty":-3.529416,"median":-2.231918,"eighty":-0.985743,"marketCap":6389385},{"date":"2024-04-05","current":-0.805692,"twenty":-3.529416,"median":-2.232163,"eighty":-0.951971,"marketCap":4947537},{"date":"2024-04-12","current":-0.666183,"twenty":-3.529416,"median":-2.232163,"eighty":-0.937467,"marketCap":4090848},{"date":"2024-04-19","current":-0.746049,"twenty":-3.529416,"median":-2.232163,"eighty":-0.925458,"marketCap":4581287},{"date":"2024-04-26","current":-0.990316,"twenty":-3.529416,"median":-2.231918,"eighty":-0.92158,"marketCap":6081264},{"date":"2024-05-03","current":-0.938133,"twenty":-3.529416,"median":-2.231918,"eighty":-0.914511,"marketCap":5760823},{"date":"2024-05-10","current":-0.941612,"twenty":-3.529416,"median":-2.231918,"eighty":-0.914511,"marketCap":5782185},{"date":"2024-05-17","current":-0.792348,"twenty":-3.529416,"median":-2.231918,"eighty":-0.90316,"marketCap":5554316},{"date":"2024-05-24","current":-0.729366,"twenty":-3.529416,"median":-2.231918,"eighty":-0.885025,"marketCap":5112819},{"date":"2024-05-31","current":-0.711081,"twenty":-3.529416,"median":-2.231918,"eighty":-0.868111,"marketCap":4984642},{"date":"2024-06-07","current":-0.584609,"twenty":-3.529416,"median":-2.231918,"eighty":-0.841478,"marketCap":4098079},{"date":"2024-06-14","current":-0.584609,"twenty":-3.529416,"median":-2.232163,"eighty":-0.825714,"marketCap":4098079},{"date":"2024-06-21","current":-0.5184,"twenty":-3.529416,"median":-2.232314,"eighty":-0.813414,"marketCap":3633959},{"date":"2024-06-28","current":-0.373304,"twenty":-3.529416,"median":-2.233626,"eighty":-0.808757,"marketCap":2616845},{"date":"2024-07-05","current":-0.318365,"twenty":-3.529416,"median":-2.233626,"eighty":-0.804561,"marketCap":2231725},{"date":"2024-07-12","current":-1.077653,"twenty":-3.529416,"median":-2.233626,"eighty":-0.801249,"marketCap":7554290},{"date":"2024-07-15","current":-1.046662,"twenty":-3.529416,"median":-2.233626,"eighty":-0.801249,"marketCap":7337043},{"date":"2024-08-02","current":-0.618418,"twenty":-3.535509,"median":-2.215749,"eighty":-0.797123,"marketCap":4335076},{"date":"2024-08-09","current":-0.442331,"twenty":-3.535509,"median":-2.205592,"eighty":-0.792348,"marketCap":3100715},{"date":"2024-08-16","current":-1.081532,"twenty":-3.535509,"median":-2.189844,"eighty":-0.792348,"marketCap":7616606},{"date":"2024-08-23","current":-1.372962,"twenty":-3.535509,"median":-2.17772,"eighty":-0.792348,"marketCap":9668985},{"date":"2024-08-30","current":-1.058865,"twenty":-3.535509,"median":-2.174327,"eighty":-0.792348,"marketCap":7456976},{"date":"2024-09-06","current":-1.343819,"twenty":-3.535509,"median":-2.166303,"eighty":-0.792348,"marketCap":9463747},{"date":"2024-09-13","current":-1.110675,"twenty":-3.535509,"median":-2.161246,"eighty":-0.792348,"marketCap":7821844},{"date":"2024-09-20","current":-1.240199,"twenty":-3.535509,"median":-2.156951,"eighty":-0.792348,"marketCap":8734012},{"date":"2024-09-27","current":-1.246676,"twenty":-3.535509,"median":-2.145374,"eighty":-0.792348,"marketCap":8779620},{"date":"2024-10-04","current":-1.279057,"twenty":-3.535509,"median":-2.13956,"eighty":-0.792348,"marketCap":9007662},{"date":"2024-10-11","current":-1.292009,"twenty":-3.535509,"median":-2.13101,"eighty":-0.792348,"marketCap":9098879},{"date":"2024-10-18","current":-1.175437,"twenty":-3.535509,"median":-2.12822,"eighty":-0.792348,"marketCap":8277928},{"date":"2024-10-25","current":-1.20458,"twenty":-3.535509,"median":-2.123577,"eighty":-0.792348,"marketCap":8483166},{"date":"2024-10-31","current":-1.207818,"twenty":-3.535509,"median":-2.107658,"eighty":-0.792348,"marketCap":8505970},{"date":"2024-11-08","current":-1.123627,"twenty":-3.535509,"median":-2.074279,"eighty":-0.792348,"marketCap":7913060},{"date":"2024-11-15","current":-1.300862,"twenty":-3.535509,"median":-2.067722,"eighty":-0.792348,"marketCap":9234956},{"date":"2024-11-22","current":-1.187744,"twenty":-3.535509,"median":-2.067722,"eighty":-0.792348,"marketCap":8431916},{"date":"2024-11-29","current":-1.184209,"twenty":-3.535509,"median":-2.049939,"eighty":-0.792348,"marketCap":8406821},{"date":"2024-12-06","current":-1.131184,"twenty":-3.535509,"median":-2.033927,"eighty":-0.792348,"marketCap":8030396},{"date":"2024-12-13","current":-1.170069,"twenty":-3.535509,"median":-2.017112,"eighty":-0.792348,"marketCap":8306441},{"date":"2024-12-20","current":-1.088765,"twenty":-3.535509,"median":-2.001581,"eighty":-0.792348,"marketCap":7729256},{"date":"2024-12-27","current":-1.021601,"twenty":-3.535509,"median":-1.986209,"eighty":-0.792348,"marketCap":7252452},{"date":"2025-01-03","current":-1.039276,"twenty":-3.535509,"median":-1.976601,"eighty":-0.792348,"marketCap":7377927},{"date":"2025-01-10","current":-1.155929,"twenty":-3.529416,"median":-1.97197,"eighty":-0.792348,"marketCap":8206061},{"date":"2025-01-17","current":-0.802434,"twenty":-3.523734,"median":-1.964077,"eighty":-0.792348,"marketCap":5696562},{"date":"2025-01-24","current":-0.887273,"twenty":-3.508918,"median":-1.953718,"eighty":-0.792348,"marketCap":6298842},{"date":"2025-01-31","current":-0.816574,"twenty":-3.487384,"median":-1.94499,"eighty":-0.792348,"marketCap":5796942},{"date":"2025-02-07","current":-0.830713,"twenty":-3.464081,"median":-1.928314,"eighty":-0.792348,"marketCap":5897322},{"date":"2025-02-14","current":-0.869598,"twenty":-3.460004,"median":-1.914564,"eighty":-0.792348,"marketCap":6173367},{"date":"2025-02-21","current":-0.862528,"twenty":-3.449367,"median":-1.905104,"eighty":-0.792348,"marketCap":6123177},{"date":"2025-02-28","current":-0.795364,"twenty":-3.435067,"median":-1.886817,"eighty":-0.792348,"marketCap":5646372},{"date":"2025-03-07","current":-0.823644,"twenty":-3.423562,"median":-1.846485,"eighty":-0.790373,"marketCap":5847132},{"date":"2025-03-14","current":-0.813039,"twenty":-3.41639,"median":-1.80975,"eighty":-0.790373,"marketCap":5771847},{"date":"2025-03-21","current":-0.841318,"twenty":-3.407348,"median":-1.782714,"eighty":-0.790373,"marketCap":5972607},{"date":"2025-03-28","current":-0.866528,"twenty":-3.405471,"median":-1.77383,"eighty":-0.790373,"marketCap":7163218},{"date":"2025-04-04","current":-0.794114,"twenty":-3.378355,"median":-1.754307,"eighty":-0.790373,"marketCap":6564600},{"date":"2025-04-11","current":-0.72147,"twenty":-3.370724,"median":-1.718749,"eighty":-0.782944,"marketCap":5964089},{"date":"2025-04-15","current":-0.748191,"twenty":-3.368231,"median":-1.703795,"eighty":-0.780869,"marketCap":6184981}],"updateTime":1744854764522}}}